Researchers from DANDRITE have played a central role in developing a new oral treatment that, for the first time ever, has shown promising results in a clinical trial involving patients – a ...

Data from Phase 2 BESTOW trial demonstrated a favorable safety and tolerability profile, substantially reducing the metabolic, neurologic, and cardiovascular toxicities commonly associated with tacrol ...

Trial management has become one of the most decisive factors in determining whether diagnostic and medtech innovations make it to market successfully. For companies developing in vitro diagnostics and ...

As neural implant technology and A.I. advance at breakneck speeds, do we need a new set of rights to protect our most intimate data — our minds?

First patient dosed in Phase 1 clinical trial evaluating AXN-2510/IMM2510 ('’2510”) monotherapy in adult patients with ...

Late-breaking results from clinical trials, debates about lifestyle choices and cardiovascular risk, and improving clinical care with generative AI are among the topics being presented by UC San ...

Completed enrollment in Part B of SIGNAL-AA Phase 2a clinical trial and increased trial size to 33 patients based on patient demand; topline data readout expected ...

Key Data Highlighting Vidofludimus Calcium's Therapeutic Potential in Multiple Sclerosis Presented at 41st Congress of ECTRIMS  – – Phase 2 CALLIPER ...

These are scenes that no longer belong to science fiction but of real-world applications of brain-computer interface (BCI) technology in China. With a multimodal BCI headband, signals from the brain ...

Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company") today reported financial results for the third quarter ...

Detailed price information for Cognition Therapeutics Inc (CGTX-Q) from The Globe and Mail including charting and trades.

With funding at a constant risk of revocation, Harvard is not out of the clear — and researchers are still fighting for their ...